Application 065094
- Type
- ANDA
- Sponsor
- IMPAX LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEMECLOCYCLINE HYDROCHLORIDE | DEMECLOCYCLINE HYDROCHLORIDE | TABLET;ORAL | 150MG | No | No |
| 002 | DEMECLOCYCLINE HYDROCHLORIDE | DEMECLOCYCLINE HYDROCHLORIDE | TABLET;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065094-001 | DEMECLOCYCLINE HYDROCHLORIDE | DEMECLOCYCLINE HYDROCHLORIDE | 150MG | TABLET / ORAL | 2004-03-22 | ||
| A065094-002 | DEMECLOCYCLINE HYDROCHLORIDE | DEMECLOCYCLINE HYDROCHLORIDE | 300MG | TABLET / ORAL | 2004-03-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A065094-001 | DEMECLOCYCLINE HYDROCHLORIDE | 150MG | TABLET / ORAL | 2004-03-22 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A065094-002 | DEMECLOCYCLINE HYDROCHLORIDE | 300MG | TABLET / ORAL | 2004-03-22 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A065094-001 | DEMECLOCYCLINE HYDROCHLORIDE | 150MG | TABLET / ORAL | 2004-03-22 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A065094-002 | DEMECLOCYCLINE HYDROCHLORIDE | 300MG | TABLET / ORAL | 2004-03-22 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A065094-001 | DEMECLOCYCLINE HYDROCHLORIDE | 150MG | TABLET / ORAL | 2004-03-22 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A065094-002 | DEMECLOCYCLINE HYDROCHLORIDE | 300MG | TABLET / ORAL | 2004-03-22 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A065094-001 | DEMECLOCYCLINE HYDROCHLORIDE | 150MG | TABLET / ORAL | 2004-03-22 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A065094-002 | DEMECLOCYCLINE HYDROCHLORIDE | 300MG | TABLET / ORAL | 2004-03-22 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Demeclocycline Hydrochloride | DEMECLOCYCLINE | Amneal Pharmaceuticals of New York LLC | 539add06-e0a0-401a-b4f6-20776084aa9c | 2026-04-02 | Warnings, Adverse reactions | Demeclocycline Hydrochloride |
| Demeclocycline Hydrochloride | DEMECLOCYCLINE HYDROCHLORIDE | PuraCap Laboratories LLC | 88e03cb0-25f5-41a5-b77f-58ab8f3be181 | 2025-12-11 | Warnings, Adverse reactions | Demeclocycline Hydrochloride DEMECLOCYCLINE HYDROCHLORIDE |
| Demeclocycline Hydrochloride | DEMECLOCYCLINE | Amneal Pharmaceuticals LLC | 4ff23e3b-e111-47fd-9776-1d89d6da049b | 2024-10-24 | Warnings, Adverse reactions | Demeclocycline Hydrochloride |
| Demeclocycline Hydrochloride | DEMECLOCYCLINE | American Health Packaging | e6adaf70-5ff9-4395-bff1-0f332090cb80 | 2024-09-26 | Warnings, Adverse reactions | Demeclocycline Hydrochloride |
| Demeclocycline Hydrochloride | DEMECLOCYCLINE HYDROCHLORIDE | Epic Pharma, LLC | 645af8f4-0843-4afb-9ddc-f587f38adb68 | 2023-11-08 | Warnings, Adverse reactions | Demeclocycline Hydrochloride DEMECLOCYCLINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.